Shire Was A Global Biotechnology Company Founded In 1986 In The Ukfocusing On Rare Diseases And Specialized Conditionsthe Company Initially Offered Calcium Supplements And Expanded Its Portfolio Through Strategic Acquisitionsbecoming A Leader In Therapeutics For Rare Diseasesin 2008Shire Relocated Its Tax Domicile To Dublinirelandand In 2019It Was Acquired By Takeda Pharmaceuticals For $62 Billion Shire S Product Offerings Included Treatments For Rare Diseasesneurological Disordersand Gastrointestinal Conditionsnotable Products Included Vyvanse For Adhd And Binge Eating Disordertherapies For Hereditary Angioedemaand Medications For Ulcerative Colitisthe Company Primarily Served Patients With Rare Genetic Disordersneurological Conditionsand Gastrointestinal Diseasesfollowing Its Acquisitionshire S Assets Were Integrated Into Takedaae S Divisionsenhancing Takeda S Capabilities In Rare Disease And Neuroscience Therapies
